ReviewInternational journal of molecular sciences2022

Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer.

Francesca Ragusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.